Szwarcberg Javier B. bought SPRB
October 20, 2025 · Form 4 insider transaction
Szwarcberg Javier B. bought 4,784 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,784
Price
$0.00
Total value
N/A
InsiderSzwarcberg Javier B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 20, 2025
Filing dateOctober 22, 2025
Shares owned after11,013
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares.; Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of SPRB common stock.